Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IVAX Insider Trading -- Ignore unavailable to you. Want to Upgrade?

To: John McCarthy who wrote (337)	12/26/1997 2:43:00 PM
From: flickerful	Read Replies (1) \| Respond to of 756

uncanny timing, isn't it... Friday December 26 12:56 PM EST Taxol May Fight Alzheimer's Disease NEW YORK (Reuters) -- Laboratory studies of the drug taxol suggest it may someday help in the battle against Alzheimer's disease. Scientists at the University of Kansas in Lawrence say the drug slowed the damage to brain cells caused by amyloid protein fibers. Animal brain cells not treated with taxol and exposed to the fibers withered and died within 48 hours, according to Dr. Mary L. Michaelis, professor of pharmacology and toxicology at the university. She notes that in all cases, "the taxol seemed to slow the degeneration of the branching ends of nerve cells," a hallmark of Alzheimer's disease. "The cells look good up to seven days after the introduction of ls from damage associated with amyloid proteins. Extensive clusters of these proteins are found in the brains of people with Alzheimer's disease. "We haven't tried this (drug) in animals or in humans," Michaelis stresses. "We don't know how this... would translate into the brain and influence the actual disease process." Copyright c 1997 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon Questions or Comments